Clatterbridge Cancer Centre NHS Foundation Trust

Metropolitan Borough of Wirral CH63 4JY

0 studies enrolling now · 3 studies all time

What they study most

Indolent Systemic Mastocytosis, Prostate Cancer, Squamous Cell Carcinoma of the Head and Neck

Studies at this site

• A Study of Xevinapant (Debio 1143) in Combination With Platinum-Based Chemotherapy and Standard Fractionation Intensity-Modulated Radiotherapy in Participants With Locally Advanced Squamous Cell Carcinoma of the Head and Neck, Suitable for Definitive Chemoradiotherapy (TrilynX) — Stopped early
• (PIONEER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, Versus Placebo in Patients With Indolent Systemic Mastocytosis — Running, not enrolling
• A Study of HSP90 Inhibitor AT13387 Alone or in Combination With Abiraterone Acetate — Completed